Mpex Pharmaceuticals
San Diego
About Mpex Pharmaceuticals
Mpex Pharmaceuticals is a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, with a particular focus on gram-negative organisms. The Company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $59.5M
- Funding stage: M&A
- Last round: Series D (Feb 2009)
- Website: mpexpharma.com
- Phone: 18588752851
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/mpex-pharmaceuticals-1151357 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.